QUANTITATIVE ASSAYS FOR PDGFR-beta IN BODY FLUIDS
The present invention is directed to the detection and quantification of total PDGFR-beta in body fluids, particularly serial changes of total PDGFR-beta levels in a subject's body fluids. Further, the invention is directed to detecting and quantitatiing total PDGFR-beta in conjunction with one...
Gespeichert in:
Hauptverfasser: | , , , |
---|---|
Format: | Patent |
Sprache: | eng ; fre ; ger |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The present invention is directed to the detection and quantification of total PDGFR-beta in body fluids, particularly serial changes of total PDGFR-beta levels in a subject's body fluids. Further, the invention is directed to detecting and quantitatiing total PDGFR-beta in conjunction with one or more other proteins, such as, oncoproteins, angiogenic factors, tumor markers, inhibitors, growth factor receptors, metastasis proteins, and tumor suppressors. The disclosed methods are diagnostic/prognostic for diseases, and useful to select therapies for patients with diseases, preferably preneoplastic/neoplastic diseases. The disclosed methods are particularly useful to monitor the status of a patient's disease, and/or to monitor how a patient is responding to a therapy. |
---|